Want to see JP:6254 full AI Analyst Report?
Top Page
Nomura Micro Science Co., Ltd.
(6254)
Select Model
Select Model
Rating:46Neutral
Price Target:
¥3,744.00
▲(27.69% Upside)
Action:Reiterated
Date:08/11/26
The score is held down primarily by mixed financial quality—sharp FY2026 revenue/earnings decline, materially higher leverage, and volatile cash generation with large negative cash-flow years—despite a history of strong profitability through FY2025. Technical indicators add additional pressure as the stock trades below key short- and mid-term moving averages with negative MACD and sub-50 RSI. Valuation is also a headwind given the high P/E (40.52) and only moderate dividend yield (2.12%).
Positive Factors
Historical operating profitability
Consistent mid-teens EBIT/EBITDA margins through FY2023–FY2025 indicate durable operating leverage and efficient cost structure in its niche. This margin profile supports reinvestment and resilience against moderate demand swings, providing a structural cushion during cyclical downturns.
Negative Factors
Sharp FY2026 revenue and earnings drop
A severe one-year revenue and earnings contraction highlights pronounced cyclicality and project-timing exposure. This reduces forecast visibility, strains margin sustainability, and can impair backlog monetization, making near-term cash flows and profitability harder to predict.
Read all positive and negative factors
Positive Factors
Negative Factors
Historical operating profitability
Consistent mid-teens EBIT/EBITDA margins through FY2023–FY2025 indicate durable operating leverage and efficient cost structure in its niche. This margin profile supports reinvestment and resilience against moderate demand swings, providing a structural cushion during cyclical downturns.
Read all positive factors
Nomura Micro Science Co., Ltd. (6254) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥154.49B
Dividend Yield2.08%
Average Volume (3M)755.66K
Price to Earnings (P/E)41.4
Beta (1Y)1.72
Revenue Growth-47.55%
EPS Growth-65.23%
CountryJP
Employees623
SectorIndustrials
Sector Strength72
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)100.29
Shares Outstanding40,608,000
10 Day Avg. Volume795,700
30 Day Avg. Volume755,656
Financial Highlights & Ratios
PEG Ratio-0.48
Price to Book (P/B)2.89
Price to Sales (P/S)2.05
P/FCF Ratio34.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥5,300.00Price Target Upside80.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)268.11
Revenue Forecast (FY)¥93.95B
Nomura Micro Science Co., Ltd. Business Overview & Revenue Model
Company Description
Nomura Micro Science Co., Ltd. specializes in water treatment technology, offering design, installation, and sales services across Japan, South Korea, Taiwan, China, and the United States. The company delivers a broad spectrum of water treatment f...
How the Company Makes Money
null...
Nomura Micro Science Co., Ltd. Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
48
Neutral
Cash Flow
35
Negative
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 56.25B | 96.36B | 73.02B | 49.60B | 31.90B |
| Gross Profit | 12.71B | 21.11B | 15.41B | 10.37B | 7.66B |
| EBITDA | 8.36B | 17.03B | 10.96B | 6.74B | 4.61B |
| Net Income | 3.82B | 10.20B | 7.98B | 5.81B | 3.29B |
Balance Sheet | |||||
| Total Assets | 110.29B | 116.78B | 70.60B | 41.92B | 27.24B |
| Cash, Cash Equivalents and Short-Term Investments | 10.43B | 17.33B | 12.14B | 14.12B | 10.08B |
| Total Debt | 52.99B | 53.20B | 22.40B | 3.47B | 2.69B |
| Total Liabilities | 70.44B | 79.77B | 41.68B | 20.52B | 11.31B |
| Stockholders Equity | 39.85B | 37.01B | 28.92B | 21.40B | 15.93B |
Cash Flow | |||||
| Free Cash Flow | 3.30B | -22.31B | -19.01B | 3.66B | 954.82M |
| Operating Cash Flow | 4.68B | -20.20B | -18.66B | 4.68B | 1.13B |
| Investing Cash Flow | -1.47B | -2.74B | 386.99M | 64.81M | 134.01M |
| Financing Cash Flow | -6.91B | 27.18B | 17.45B | -24.90M | -881.82M |
Nomura Micro Science Co., Ltd. Technical Analysis
Negative
2932.00
Price Trends
4379.40
Negative
4116.20
Negative
3677.33
Positive
Market Momentum
-101.57
Negative
45.18
Neutral
35.14
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6254, the sentiment is Negative. The current price of 2932 is below the 20-day moving average (MA) of 4053.25, below the 50-day MA of 4379.40, and below the 200-day MA of 3677.33, indicating a neutral trend. The MACD of -101.57 indicates Negative momentum. The RSI at 45.18 is Neutral, neither overbought nor oversold. The STOCH value of 35.14 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6254.
Nomura Micro Science Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥76.65B | 13.75 | ― | 3.95% | 6.49% | 36.18% | |
70 Outperform | ¥81.75B | 10.90 | ― | 3.09% | 0.93% | 212.09% | |
69 Neutral | ¥98.90B | 19.56 | ― | 2.79% | 7.86% | 19.30% | |
65 Neutral | ¥236.57B | 19.89 | 9.52% | 1.33% | 10.77% | 147.98% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | ¥6.34B | 69.80 | ― | 1.65% | 9.69% | 29.00% | |
46 Neutral | ¥154.49B | 41.37 | ― | 2.86% | -47.55% | -65.23% |
* Industrials Sector Average
JP:6254
Nomura Micro Science Co., Ltd.
3,900.00
930.69
31.34%
JP:6376
Nikkiso Co., Ltd.
4,385.00
3,042.87
226.72%
JP:6237
Iwaki Co. Ltd.
4,635.00
2,177.48
88.60%
JP:6363
Torishima Pump Mfg.Co., Ltd.
3,160.00
1,143.49
56.71%
JP:6381
ANEST IWATA Corp.
1,955.00
487.92
33.26%
JP:6495
Miyairi Valve Mfg.Co., Ltd.
127.00
11.08
9.56%
Nomura Micro Science Co., Ltd. Corporate Events
Nomura Micro Science Sees Profit Slump in Q1 but Sticks to Aggressive Full-Year Growth and Dividend Plan
Aug 7, 2026
Nomura Micro Science reported consolidated net sales of ¥9.2 billion for the three months ended June 30, 2026, down 25.8% year-on-year, with operating profit dropping 54.4% to ¥628 million and profit attributable to owners of parent halv...
Nomura Micro Science Launches Performance-Linked Stock Options for Employees
Jul 15, 2026
Nomura Micro Science Co., Ltd. has approved the issuance of its 9th series of stock options to executive officers and employees, allocating 2,545 units that each correspond to 100 common shares. The scheme is designed to strengthen the link betwee...
Nomura Micro Science Extends U.S. Dollar Loan Maturities to Ease Cash Flow
Jun 24, 2026
Nomura Micro Science Co., Ltd. has postponed the repayment dates on significant U.S. dollar-denominated loans used to finance working capital for a large water treatment systems project in the United States. The move follows a board decision on Ju...
Nomura Micro Science Corrects FY2026 Cash Flow Figures After Audit Review
Jun 16, 2026
Nomura Micro Science Co., Ltd. announced corrections to its consolidated earnings report for the fiscal year ended March 31, 2026, after errors were discovered during the statutory audit review. The revisions affect the consolidated statement of c...
Nomura Micro Science Raises Annual Dividend Despite Profit Decline
May 20, 2026
Nomura Micro Science Co., Ltd. has resolved to pay a year-end dividend of 61 yen per share for the fiscal year ended March 31, 2026, with a total dividend payout of 2,335 million yen subject to approval at the June shareholders’ meeting. Thi...
Nomura Micro Science Raises Dividend Forecast Despite Earnings Lull
May 14, 2026
Nomura Micro Science has revised its dividend forecast for the fiscal year ending March 2026, raising the planned year-end dividend from 50 yen to 61 yen per share and the total annual dividend from 70 yen to 81 yen. Despite a temporary lull in or...
Nomura Micro Science Sees Profit Slump but Signals Strong Earnings Rebound in FY2027
May 14, 2026
Nomura Micro Science reported a sharp downturn for the fiscal year ended March 31, 2026, with net sales dropping 41.6% to ¥56.25 billion and profit attributable to owners of parent plunging 62.6% to ¥3.82 billion. Profitability ratios al...
Nomura Micro Science Lifts Year-End Dividend Forecast Despite Earnings Lull
May 14, 2026
Nomura Micro Science revised its dividend forecast for the fiscal year ending March 2026, raising the planned year-end dividend from ¥50 to ¥61 per share and total annual dividends to ¥81. This adjustment comes despite a temporary d...
Nomura Micro Science Forecasts Sharp Earnings Rebound After Profit Slump
May 14, 2026
Nomura Micro Science reported a sharp downturn for the fiscal year ended March 31, 2026, with net sales falling 41.6% to ¥56.2 billion and profit attributable to owners of parent dropping 62.6% to ¥3.8 billion as margins contracted. Desp...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.